» Articles » PMID: 35062998

Correction To: ARNTL Hypermethylation Promotes Tumorigenesis and Inhibits Cisplatin Sensitivity by Activating CDK5 Transcription in Nasopharyngeal Carcinoma

Overview
Publisher Biomed Central
Specialty Oncology
Date 2022 Jan 22
PMID 35062998
Authors
Affiliations
Soon will be listed here.
References
1.
Peng H, Zhang J, Zhang P, Chen L, Tang L, Yang X . ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 2019; 38(1):11. PMC: 6325889. DOI: 10.1186/s13046-018-0997-7. View